Cargando…
NKD2 Trigger NF-κB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation
NKD inhibitor of WNT signaling pathway 2 (NKD2) is an emerging player in cancer onset and progression. Here, it was confirmed that THCA patients have robustly expressed NKD2, which was linked to an advanced pathologic stage. The prognosis was worse for those with high NKD2 levels. Functionally, ecto...
Autores principales: | Ke, Shaoying, Pan, Qunxiong, Wang, Congren, Su, Zijian, Li, Mingzhu, Liu, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518272/ https://www.ncbi.nlm.nih.gov/pubmed/36820951 http://dx.doi.org/10.1007/s12033-023-00665-7 |
Ejemplares similares
-
Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma
por: Li, Huiqiang, et al.
Publicado: (2019) -
Circ_0001658 regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and affects the progress of papillary thyroid carcinoma
por: Liu, Xiaoyu, et al.
Publicado: (2022) -
miR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1
por: Wang, Congren, et al.
Publicado: (2015) -
Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma
por: Li, Lijun, et al.
Publicado: (2023) -
NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma
por: Gao, Yu, et al.
Publicado: (2022)